254452-96-5 / Calcium (3R,5R,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate / (3R,5R)-Pitavastatin calcium / (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt (2:1) / (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt / Pitavastatin (3R,5R)-Isomer / Calcium;(E,3R,5R)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate / C50H46CaF2N2O8 / Pitavastatin Impurity 93 / 5-epi-NK-104 / 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5R,6E)-; 5-epi-NK-104; (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid hemicalcium salt; (3R,5R,6E)-Pit / (3R, 5R)-Pitavastatin Calcium Salt / Pitavastatin Impurity M / Pitavastatin Calcium 1(R,R) / SCHEMBL355044 / 254452-96-5(free base) / Pitavastatin -3R,5R- Calcium salt / AKOS015967308 / IP145450 / G83065
187 Ų
14
63
0
626
880.2848136